Dangerous Drug Attorney Jeffrey D. DeCarlo Comments on ‘openFDA’ Website’s Benefit to Consumers
Miami, FL (PRWEB) August 17, 2014 -- The U.S. Food and Drug Administration has launched its openFDA project which provides easy access to important drug and medical device information, including drug recalls, a move that Jeffrey D. DeCarlo, P.A., said provides a significant benefit for consumers.
Commenting on a July 17 Regulatory Affairs Professionals Society report about the launch of the openFDA website, dangerous drug attorney Jeffrey D. DeCarlo said the project will lead to an increased awareness of adverse drug events.
“Previously, many reports of adverse drug events were only available through Freedom of Information Act requests,” DeCarlo explained. “This FDA project serves to enlighten patients, doctors, pharmacists and others. It allows everyone to be informed of possibly dangerous drugs or devices in a timely manner.”
The openFDA site allows consumers access to information about drug recalls, reported adverse reactions and label information.
“No doubt, this will be a valuable tool for consumers for years to come,” DeCarlo explained. “Drug and medical device manufacturers have a responsibility to adequately test their products for dangerous side effects, provide all necessary information on warning labels and to address product flaws in a timely manner. When they don’t, consumers using their products may suffer adverse side effects or may even die. The openFDA website represents an important step in educating consumers about the potential side effects and adverse reactions a product may cause. They will have millions of adverse event and medication error reports available when they need the information.”
According to the Regulatory Affairs Professionals Society article, a beta version of the openFDA website was launched in June 2014. The openFDA initiative was born in 2012 after the federal government urged the FDA and other agencies to implement a “digital strategy” aimed to make governmental information accessible to the public.
The Regulatory Affairs Professionals Society said the FDA tailored the openFDA initiative toward consumers and software developers looking for information about drug adverse event data.
According to the FDA’s Voice blog (“OpenFDA Provides Ready Access to Recall Data,” July 16), consumers, developers and researchers are allowed direct access to FDA databases dating back to 2004. The blog noted that the FDA anticipates researchers and developers will use this information as part of independent studies and research projects on various products.
The Regulatory Affairs Professionals Society report cited is “FDA Wants to Make Product Recalls Easier to Track.”
About Jeffrey D. DeCarlo, P.A.
Attorney Jeffrey D. DeCarlo is a nationally recognized pharmaceutical injury lawyer who has protected the rights of injury victims for over 15 years. His office is in Miami, Fla., but he serves clients throughout the State of Florida and the United States. Attorney Jeffrey D. DeCarlo is a member of both the Million Dollar Advocates Forum and Multi-Million Dollar Advocates Forum, reserved for a small percentage of attorneys who have secured multi-million dollar verdicts and settlements. In addition to handling dangerous drug claims, attorney Jeffrey D. DeCarlo also handles cases involving defective medical devices, medical malpractice, car accidents, and a variety of catastrophic personal injury cases.
If you or a loved one was injured by a dangerous drug or defective medical device, call 877-572-0065 today for a free case consultation. Visit http://www.decarlolaw.com.
Jeffrey D. DeCarlo, P.A., is located at:
4500 Biscayne Blvd #201
Miami, FL 33137
Jacob M Del Hagen, Big Voodoo Interactive, http://www.bigvoodoo.com, +1 (413) 650-0593, [email protected]
Share this article